What is Persyst Development?
Persyst Development stands as the global leader in EEG software, offering sophisticated tools for monitoring and analysis. Their product suite, including the Persyst 15 EEG Review and Analysis Software and Persyst Mobile, is designed to serve a wide spectrum of healthcare providers, from large institutions to smaller clinics, thereby enhancing patient care capabilities. The company's strategy involves close collaboration with leading EEG manufacturers to ensure seamless integration and broad accessibility of their advanced neurodiagnostic solutions. Persyst's dedication to research and validation fuels continuous innovation in the field.
How much funding has Persyst Development raised?
Persyst Development has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Persyst Development?
With the backing of substantial late-stage capital, Persyst Development is poised for significant scaling and further market penetration. This strategic investment is likely to fuel advancements in their core EEG software technologies, potentially expanding into new diagnostic areas or enhancing existing analytical capabilities. The company's focus on integration with major manufacturers suggests a continued emphasis on partnerships to broaden their reach and solidify their market dominance in neurodiagnostics. Future developments may also include exploring new applications for their technology in research or clinical settings, further cementing their role as an innovator.
See full Persyst Development company page
